The ongoing revolution in genomic science is having an impact on many facets of modern life, including toxic tort litigation.
The ongoing revolution in genomic science is having an impact on many facets of modern life, including toxic tort litigation. This point was apparent at the recently held American Conference Institute’s 23rd National Forum on Asbestos Claims & Litigation (May 21-23, 2018) in Chicago, where I presented with my colleague Kirk Hartley (also of ToxicoGenomica) on a panel titled “The Meso Gene.” On the panel, we covered various topics related to waging a genomics defense in toxic tort cases, including the following:
You can download a copy of my slides below.
Also, don’t forget to check out my recent blog post on recognizing legal cases where a genetic defense will be most beneficial.
Download a complimentary copy of Dr. Schwartz’s talk titled: “The Meso Gene”: Evaluating Predispositions to Certain Types of Cancer.
Complete the form to claim your complimentary copy of Dr. Schwartz's presentation at the ACI's 23rd National Forum on Asbestos Claims and Litigation.
On Wednesday July 8, 2020, Dr. David Schwartz of Innovative Science Solutions presented at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. A complimentary copy of the panel presentation is now available for download. Read more
Dr. David Schwartz of Innovative Science Solutions will be presenting at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. Read more
Plaintiff experts having been asserting for decades that all mesotheliomas must be linked to some asbestos exposure. Indeed, this has led to the erroneous (but widespread) view that mesothelioma is a signature disease, only caused by asbestos exposure. Read more
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us